Skip to main content

LimmaTech Biologics

Schlieren, Switzerland

LimmaTech Biologics is a biotech company that develops vaccines to prevent microbial infections and address antimicrobial resistance.

$6.5M raised
Feb 2025
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about LimmaTech Biologics

How much funding has LimmaTech Biologics raised?
LimmaTech Biologics has raised $6.5M in total funding. The most recent round was Grant. The last funding was announced in February 2025.
Who are LimmaTech Biologics's investors?
LimmaTech Biologics's investors include AXA Investment Managers, Adjuvant Capital, CARB-X, Repair Impact Fund, Tenmile.
Where is LimmaTech Biologics headquartered?
LimmaTech Biologics is headquartered in Schlieren, Switzerland.
What does LimmaTech Biologics do?
LimmaTech Biologics is a biotech company that develops vaccines to prevent microbial infections and address antimicrobial resistance.
What stage is LimmaTech Biologics at?
LimmaTech Biologics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"LimmaTech Biologics — Funding & Investors." VCBacked, February 17, 2025, https://www.vcbacked.co/company/limmatech-biologics. Accessed July 1, 2026.
APA
VCBacked. (2025). LimmaTech Biologics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/limmatech-biologics
Wikipedia (cite web)
{{cite web |title=LimmaTech Biologics — Funding & Investors |url=https://www.vcbacked.co/company/limmatech-biologics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .